| Upon completing the course, you will able to: | |
| Discuss the epidemiology of HCV and demographic characteristics of HCV infection. | |
| List elements of a comprehensive strategy to prevent and control hepatitis C virus infection. | |
| Provide specific advice to persons with high-risk drug or sexual practices as part of HCV prevention strategy. | |
| Identify persons who should be tested routinely for hepatitis C virus infection. | |
| Identify persons with chronic hepatitis C who are recommended for treatment and those that are not. | |
| Provide HCV-specific information and prevention messages to infected persons and individuals at risk. |
| Introduction | |
| Figure 1. Reported cases of acute hepatitis C by selected risk factors–United States, 1983-1996 | |
| Background | |
| Epidemiology | |
| Demographic Characteristics | |
| Figure 2. Prevalence of hepatitis C virus (HCV) infection by age and race/ethnicity–United States, 1988–1994 | |
| Transmission Modes | |
| Screening and Diagnostic Tests | |
| Serologic Assays | |
| Clinical Features and Natural History | |
| Acute HCV Infection | |
| Chronic HCV Infection | |
| Clinical Management and Treatment | |
| Prevention and Control Recommendations | |
| Rationale | |
| Primary Prevention Recommendations | |
| Blood, Plasma Derivatives, Organs, Tissues, and Semen | |
| High-Risk Drug and Sexual Practices | |
| Percutaneous Exposures to Blood in Health-Care and Other Settings | |
| Health-Care Settings | |
| Other Settings | |
| Secondary Prevention Recommendations | |
| Persons for Whom Routine HCV Testing Is Recommended | |
| Persons Who Have Ever Injected Illegal Drugs | |
| Persons With Selected Medical Conditions | |
| Prior Recipients of Blood Transfusions or Organ Transplants | |
| Health-Care, Emergency Medical, and Public Safety Workers After Needle Sticks, Sharps, or Mucosal Exposures to HCV-Positive Blood | |
| Post-Test |
© 2009 Homestead Schools, Inc. - Webmaster: ITSYS Solutions